Viriom Inc logo — Innovative Treatments for HIV and Chronic HBV Infections Wor...

Viriom Inc

Innovative Treatments for HIV and Chronic HBV Infections Worldwide

Founded 2009 United States San Diego, United States 9 employees Convertible Note Total: $35.41M Biotechnology, Health Care +1

General Information

Company Name Viriom Inc
Founded Year 2009
Location United States San Diego, United States
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Viriom Inc. To contact Viriom Inc, visit viriom.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Viriom Inc compare?

A PDF of Viriom Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Viriom Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Viriom Inc

Viriom Inc. is a biotech firm founded in 2009 with a focus on developing innovative and affordable medications for life-threatening infections such as HIV and HBV. The company holds an exclusive global license from Hoffmann-La Roche and its lead compounds - Elpida/elsulfavirine and VM1500A - are in advanced phases. In addition, Viriom has proprietary drug candidates VM2500 and VM3500 LAI formulations, as well as combinations involving cell, vaccine, and antibody drugs aimed at treating, preventing, and curing HIV and chronic HBV infections worldwide. The last investment round, a $12.50M Convertible Note investment from Pharmstandard, took place on 06 December 2017. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries.

Business keywords: biotech firm, medications, HIV, HBV, global license, drug development, commercial stage, novel medicines, infections, treatment, prevention, cure, proprietary drug candidates, phase 3, Hoffmann-La Roche

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $12.50M 1
Pharmstandard
06 Dec 2017
Convertible Note $2.56M 1
Torrey Pines Investment
06 Jun 2017
Convertible Note $2.35M 3
Skolkovo Foundation, Torrey Pines Investment +1
11 May 2016
Convertible Note $3.00M 1
Torrey Pines Investment
01 Sep 2015
Seed Round $5.00M 2
MIT RF, ChemRar Ventures
01 Dec 2012
Non Equity Assistance $5.00M 1
MIT RF
01 Sep 2010
Seed Round $5.00M 1
ChemRar Ventures
01 Dec 2009
Seed Round Undisclosed 1
Torrey Pines Investment
27 Jul 2009

Viriom Inc Alternatives & Competitors

View All Alternatives
Viriom Inc vs

Developing novel vaccines to cure HIV infection

Seed
5 employees
Biotechnology, Health Care
Viriom Inc vs

Pioneering the future of hepatitis C treatment with innovative antiviral therapies

Private Equity
Biotechnology, Health Care
Viriom Inc vs

292 million people have chronic hepatitis B. We're developing the cure.

6 employees
Biotechnology, Health Care

FAQ About Viriom Inc

Innovative Treatments for HIV and Chronic HBV Infections Worldwide
Viriom Inc was founded in 2009.
Viriom Inc is headquartered in San Diego, United States.
Viriom Inc operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biotech firm, medications, HIV and HBV.
Viriom Inc has approximately 9 employees.
Viriom Inc has completed 8 funding rounds, raising a total of $35.41M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Viriom Inc include AELIX Therapeutics, Anadys Pharmaceuticals, Replicor Inc., Allecra Therapeutics, Destiny Pharma Limited - In Liquidation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Viriom Inc and AELIX Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Viriom Inc, https://bouncewatch.com/company/viriom, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes